three cycles (toripalimab + cetuximab + platinum) Clinical Trials

1 actively recruiting trial

Also known as: Toripalimab + Cetuximab + Platinum

Pipeline

Phase 2: 1

Top Sponsors

Eye & ENT Hospital of Fudan University1

Indications

Locally Advanced Hypopharyngeal Carcinoma1
Cancer1

Other1 trial

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.